Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC (HKMPY) Stock Competitors & Peer Comparison
See (HKMPY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HKMPY | $48.27 | +0.00% | 5.3B | 14.45 | $3.34 | +3.31% |
| MKGAF | $130.71 | +0.55% | 57.2B | 17.12 | $7.68 | +1.91% |
| MKKGY | $25.82 | -0.88% | 54.2B | 16.81 | $1.54 | +1.93% |
| TKPHF | $29.45 | +3.11% | 46B | 50.78 | $0.58 | +4.52% |
| HLNCF | $4.69 | -6.57% | 42.1B | 22.33 | $0.21 | +2.72% |
| IPSEY | $31.62 | +1.54% | 41.8B | 20.14 | $1.57 | +0.82% |
| SDZNY | $58.61 | -1.27% | 25.3B | 112.88 | $0.52 | +1.15% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.32 | +0.00% | 16.4B | -95.47 | -$0.15 | N/A |
| SGIOY | $8.90 | -2.41% | 15.1B | 13.09 | $0.68 | +1.78% |
Stock Comparison
HKMPY vs MKGAF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, MKGAF has a market cap of 57.2B. Regarding current trading prices, HKMPY is priced at $48.27, while MKGAF trades at $130.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas MKGAF's P/E ratio is 17.12. In terms of profitability, HKMPY's ROE is +0.16%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, HKMPY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check MKGAF's competition here
HKMPY vs MKKGY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, MKKGY has a market cap of 54.2B. Regarding current trading prices, HKMPY is priced at $48.27, while MKKGY trades at $25.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas MKKGY's P/E ratio is 16.81. In terms of profitability, HKMPY's ROE is +0.16%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, HKMPY is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check MKKGY's competition here
HKMPY vs TKPHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TKPHF has a market cap of 46B. Regarding current trading prices, HKMPY is priced at $48.27, while TKPHF trades at $29.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TKPHF's P/E ratio is 50.78. In terms of profitability, HKMPY's ROE is +0.16%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, HKMPY is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check TKPHF's competition here
HKMPY vs HLNCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HLNCF has a market cap of 42.1B. Regarding current trading prices, HKMPY is priced at $48.27, while HLNCF trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HLNCF's P/E ratio is 22.33. In terms of profitability, HKMPY's ROE is +0.16%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, HKMPY is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check HLNCF's competition here
HKMPY vs IPSEY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, IPSEY has a market cap of 41.8B. Regarding current trading prices, HKMPY is priced at $48.27, while IPSEY trades at $31.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas IPSEY's P/E ratio is 20.14. In terms of profitability, HKMPY's ROE is +0.16%, compared to IPSEY's ROE of +0.08%. Regarding short-term risk, HKMPY is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check IPSEY's competition here
HKMPY vs SDZNY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SDZNY has a market cap of 25.3B. Regarding current trading prices, HKMPY is priced at $48.27, while SDZNY trades at $58.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SDZNY's P/E ratio is 112.88. In terms of profitability, HKMPY's ROE is +0.16%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, HKMPY is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check SDZNY's competition here
HKMPY vs ESALY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, HKMPY is priced at $48.27, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HKMPY's ROE is +0.16%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HKMPY is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check ESALY's competition here
HKMPY vs TEVJF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TEVJF has a market cap of 16.4B. Regarding current trading prices, HKMPY is priced at $48.27, while TEVJF trades at $14.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TEVJF's P/E ratio is -95.47. In terms of profitability, HKMPY's ROE is +0.16%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, HKMPY is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check TEVJF's competition here
HKMPY vs SGIOY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SGIOY has a market cap of 15.1B. Regarding current trading prices, HKMPY is priced at $48.27, while SGIOY trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SGIOY's P/E ratio is 13.09. In terms of profitability, HKMPY's ROE is +0.16%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, HKMPY is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check SGIOY's competition here
HKMPY vs SGIOF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, HKMPY is priced at $48.27, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, HKMPY's ROE is +0.16%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, HKMPY is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check SGIOF's competition here
HKMPY vs BIOVF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, HKMPY is priced at $48.27, while BIOVF trades at $28.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas BIOVF's P/E ratio is 22.11. In terms of profitability, HKMPY's ROE is +0.16%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, HKMPY is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check BIOVF's competition here
HKMPY vs IPSEF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, HKMPY is priced at $48.27, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas IPSEF's P/E ratio is 18.16. In terms of profitability, HKMPY's ROE is +0.16%, compared to IPSEF's ROE of +0.08%. Regarding short-term risk, HKMPY is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check IPSEF's competition here
HKMPY vs SFOSF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SFOSF has a market cap of 8.8B. Regarding current trading prices, HKMPY is priced at $48.27, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, HKMPY's ROE is +0.16%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, HKMPY is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check SFOSF's competition here
HKMPY vs ESALF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ESALF has a market cap of 8.7B. Regarding current trading prices, HKMPY is priced at $48.27, while ESALF trades at $31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ESALF's P/E ratio is 27.93. In terms of profitability, HKMPY's ROE is +0.16%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, HKMPY is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check ESALF's competition here
HKMPY vs ESAIY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ESAIY has a market cap of 8.7B. Regarding current trading prices, HKMPY is priced at $48.27, while ESAIY trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ESAIY's P/E ratio is 27.43. In terms of profitability, HKMPY's ROE is +0.16%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, HKMPY is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check ESAIY's competition here
HKMPY vs GZPHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, GZPHF has a market cap of 5.8B. Regarding current trading prices, HKMPY is priced at $48.27, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, HKMPY's ROE is +0.16%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, HKMPY is less volatile compared to GZPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check GZPHF's competition here
HKMPY vs HKMPF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HKMPF has a market cap of 5.3B. Regarding current trading prices, HKMPY is priced at $48.27, while HKMPF trades at $23.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HKMPF's P/E ratio is 14.35. In terms of profitability, HKMPY's ROE is +0.16%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, HKMPY is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check HKMPF's competition here
HKMPY vs SGFEF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, HKMPY is priced at $48.27, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SGFEF's P/E ratio is 25.19. In terms of profitability, HKMPY's ROE is +0.16%, compared to SGFEF's ROE of +0.17%. Regarding short-term risk, HKMPY is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check SGFEF's competition here
HKMPY vs WIBFF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, HKMPY is priced at $48.27, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, HKMPY's ROE is +0.16%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, HKMPY is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check WIBFF's competition here
HKMPY vs HLBBF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HLBBF has a market cap of 4.4B. Regarding current trading prices, HKMPY is priced at $48.27, while HLBBF trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HLBBF's P/E ratio is 10.61. In terms of profitability, HKMPY's ROE is +0.16%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, HKMPY is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check HLBBF's competition here
HKMPY vs HLUBF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HLUBF has a market cap of 4.3B. Regarding current trading prices, HKMPY is priced at $48.27, while HLUBF trades at $4.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HLUBF's P/E ratio is 8.83. In terms of profitability, HKMPY's ROE is +0.16%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, HKMPY is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check HLUBF's competition here
HKMPY vs SMDPY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SMDPY has a market cap of 4B. Regarding current trading prices, HKMPY is priced at $48.27, while SMDPY trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SMDPY's P/E ratio is 25.00. In terms of profitability, HKMPY's ROE is +0.16%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, HKMPY is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check SMDPY's competition here
HKMPY vs LVZPF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LVZPF has a market cap of 3.6B. Regarding current trading prices, HKMPY is priced at $48.27, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, HKMPY's ROE is +0.16%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, HKMPY is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check LVZPF's competition here
HKMPY vs DNPUF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, DNPUF has a market cap of 3.6B. Regarding current trading prices, HKMPY is priced at $48.27, while DNPUF trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas DNPUF's P/E ratio is 22.43. In terms of profitability, HKMPY's ROE is +0.16%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, HKMPY is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check DNPUF's competition here
HKMPY vs CHSYF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, HKMPY is priced at $48.27, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, HKMPY's ROE is +0.16%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, HKMPY is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CHSYF's competition here
HKMPY vs ULIHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, HKMPY is priced at $48.27, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, HKMPY's ROE is +0.16%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, HKMPY is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check ULIHF's competition here
HKMPY vs APNHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, HKMPY is priced at $48.27, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas APNHF's P/E ratio is 12.72. In terms of profitability, HKMPY's ROE is +0.16%, compared to APNHF's ROE of +0.05%. Regarding short-term risk, HKMPY is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check APNHF's competition here
HKMPY vs INVVY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, HKMPY is priced at $48.27, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HKMPY's ROE is +0.16%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, HKMPY is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check INVVY's competition here
HKMPY vs IZQVF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, HKMPY is priced at $48.27, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HKMPY's ROE is +0.16%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, HKMPY is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check IZQVF's competition here
HKMPY vs LBTSF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, HKMPY is priced at $48.27, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, HKMPY's ROE is +0.16%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, HKMPY is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check LBTSF's competition here
HKMPY vs APNHY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, HKMPY is priced at $48.27, while APNHY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas APNHY's P/E ratio is 11.18. In terms of profitability, HKMPY's ROE is +0.16%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, HKMPY is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check APNHY's competition here
HKMPY vs HMDCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, HKMPY is priced at $48.27, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, HKMPY's ROE is +0.16%, compared to HMDCF's ROE of +0.03%. Regarding short-term risk, HKMPY is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check HMDCF's competition here
HKMPY vs HYPMY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HYPMY has a market cap of 2.6B. Regarding current trading prices, HKMPY is priced at $48.27, while HYPMY trades at $4.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HYPMY's P/E ratio is 18.36. In terms of profitability, HKMPY's ROE is +0.16%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, HKMPY is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check HYPMY's competition here
HKMPY vs THCBF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, HKMPY is priced at $48.27, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas THCBF's P/E ratio is -0.10. In terms of profitability, HKMPY's ROE is +0.16%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, HKMPY is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check THCBF's competition here
HKMPY vs CURLF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CURLF has a market cap of 2.3B. Regarding current trading prices, HKMPY is priced at $48.27, while CURLF trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CURLF's P/E ratio is -8.43. In terms of profitability, HKMPY's ROE is +0.16%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, HKMPY is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CURLF's competition here
HKMPY vs DMPHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, HKMPY is priced at $48.27, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, HKMPY's ROE is +0.16%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, HKMPY is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check DMPHF's competition here
HKMPY vs HTSUF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, HKMPY is priced at $48.27, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HTSUF's P/E ratio is 16.08. In terms of profitability, HKMPY's ROE is +0.16%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, HKMPY is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check HTSUF's competition here
HKMPY vs LJUIF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, HKMPY is priced at $48.27, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, HKMPY's ROE is +0.16%, compared to LJUIF's ROE of +0.15%. Regarding short-term risk, HKMPY is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check LJUIF's competition here
HKMPY vs GTBIF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, GTBIF has a market cap of 2B. Regarding current trading prices, HKMPY is priced at $48.27, while GTBIF trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas GTBIF's P/E ratio is 78.09. In terms of profitability, HKMPY's ROE is +0.16%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, HKMPY is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check GTBIF's competition here
HKMPY vs CASBF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CASBF has a market cap of 1.9B. Regarding current trading prices, HKMPY is priced at $48.27, while CASBF trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CASBF's P/E ratio is -29.81. In terms of profitability, HKMPY's ROE is +0.16%, compared to CASBF's ROE of -0.04%. Regarding short-term risk, HKMPY is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check CASBF's competition here
HKMPY vs ARSUF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, HKMPY is priced at $48.27, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, HKMPY's ROE is +0.16%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, HKMPY is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check ARSUF's competition here
HKMPY vs TSMRF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, HKMPY is priced at $48.27, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TSMRF's P/E ratio is 8.21. In terms of profitability, HKMPY's ROE is +0.16%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, HKMPY is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check TSMRF's competition here
HKMPY vs NPNKF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, HKMPY is priced at $48.27, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas NPNKF's P/E ratio is 7.82. In terms of profitability, HKMPY's ROE is +0.16%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, HKMPY is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check NPNKF's competition here
HKMPY vs TCNNF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TCNNF has a market cap of 1.7B. Regarding current trading prices, HKMPY is priced at $48.27, while TCNNF trades at $8.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TCNNF's P/E ratio is -10.89. In terms of profitability, HKMPY's ROE is +0.16%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, HKMPY is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check TCNNF's competition here
HKMPY vs MITPF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, HKMPY is priced at $48.27, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas MITPF's P/E ratio is -10.81. In terms of profitability, HKMPY's ROE is +0.16%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, HKMPY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check MITPF's competition here
HKMPY vs KARBF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, HKMPY is priced at $48.27, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HKMPY's ROE is +0.16%, compared to KARBF's ROE of N/A. Regarding short-term risk, HKMPY is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check KARBF's competition here
HKMPY vs EVOTF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, HKMPY is priced at $48.27, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas EVOTF's P/E ratio is -8.27. In terms of profitability, HKMPY's ROE is +0.16%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, HKMPY is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check EVOTF's competition here
HKMPY vs NPPNY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, HKMPY is priced at $48.27, while NPPNY trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas NPPNY's P/E ratio is 6.55. In terms of profitability, HKMPY's ROE is +0.16%, compared to NPPNY's ROE of +0.14%. Regarding short-term risk, HKMPY is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check NPPNY's competition here
HKMPY vs SHEZF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, HKMPY is priced at $48.27, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, HKMPY's ROE is +0.16%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, HKMPY is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check SHEZF's competition here
HKMPY vs CHIZF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, HKMPY is priced at $48.27, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, HKMPY's ROE is +0.16%, compared to CHIZF's ROE of +0.00%. Regarding short-term risk, HKMPY is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check CHIZF's competition here
HKMPY vs SWGHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, HKMPY is priced at $48.27, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, HKMPY's ROE is +0.16%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, HKMPY is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check SWGHF's competition here
HKMPY vs KSPHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, HKMPY is priced at $48.27, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas KSPHF's P/E ratio is 16.37. In terms of profitability, HKMPY's ROE is +0.16%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, HKMPY is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check KSPHF's competition here
HKMPY vs GNMLF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, HKMPY is priced at $48.27, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, HKMPY's ROE is +0.16%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, HKMPY is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check GNMLF's competition here
HKMPY vs KKPCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, KKPCF has a market cap of 1.1B. Regarding current trading prices, HKMPY is priced at $48.27, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, HKMPY's ROE is +0.16%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, HKMPY is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check KKPCF's competition here
HKMPY vs BIOGY Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, BIOGY has a market cap of 982.5M. Regarding current trading prices, HKMPY is priced at $48.27, while BIOGY trades at $9.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas BIOGY's P/E ratio is 33.66. In terms of profitability, HKMPY's ROE is +0.16%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, HKMPY is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check BIOGY's competition here
HKMPY vs SHPHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, HKMPY is priced at $48.27, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, HKMPY's ROE is +0.16%, compared to SHPHF's ROE of -0.05%. Regarding short-term risk, HKMPY is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check SHPHF's competition here
HKMPY vs LVTTF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LVTTF has a market cap of 891.1M. Regarding current trading prices, HKMPY is priced at $48.27, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, HKMPY's ROE is +0.16%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, HKMPY is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check LVTTF's competition here
HKMPY vs EVRRF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, EVRRF has a market cap of 887.3M. Regarding current trading prices, HKMPY is priced at $48.27, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, HKMPY's ROE is +0.16%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, HKMPY is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check EVRRF's competition here
HKMPY vs NRXCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, NRXCF has a market cap of 842.5M. Regarding current trading prices, HKMPY is priced at $48.27, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, HKMPY's ROE is +0.16%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, HKMPY is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check NRXCF's competition here
HKMPY vs TWAPF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, HKMPY is priced at $48.27, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, HKMPY's ROE is +0.16%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, HKMPY is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check TWAPF's competition here
HKMPY vs CSWYF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, HKMPY is priced at $48.27, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, HKMPY's ROE is +0.16%, compared to CSWYF's ROE of +0.04%. Regarding short-term risk, HKMPY is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CSWYF's competition here
HKMPY vs TRXPF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, HKMPY is priced at $48.27, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HKMPY's ROE is +0.16%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, HKMPY is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check TRXPF's competition here
HKMPY vs YIHCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, HKMPY is priced at $48.27, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HKMPY's ROE is +0.16%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, HKMPY is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check YIHCF's competition here
HKMPY vs TRSSF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, HKMPY is priced at $48.27, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HKMPY's ROE is +0.16%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, HKMPY is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check TRSSF's competition here
HKMPY vs SWDCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, SWDCF has a market cap of 600.2M. Regarding current trading prices, HKMPY is priced at $48.27, while SWDCF trades at $3.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas SWDCF's P/E ratio is 93.88. In terms of profitability, HKMPY's ROE is +0.16%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HKMPY is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check SWDCF's competition here
HKMPY vs VRNOF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, VRNOF has a market cap of 578.8M. Regarding current trading prices, HKMPY is priced at $48.27, while VRNOF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas VRNOF's P/E ratio is -1.62. In terms of profitability, HKMPY's ROE is +0.16%, compared to VRNOF's ROE of -0.26%. Regarding short-term risk, HKMPY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check VRNOF's competition here
HKMPY vs AIHLF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, HKMPY is priced at $48.27, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, HKMPY's ROE is +0.16%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HKMPY is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check AIHLF's competition here
HKMPY vs ELTP Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ELTP has a market cap of 546.1M. Regarding current trading prices, HKMPY is priced at $48.27, while ELTP trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ELTP's P/E ratio is -25.50. In terms of profitability, HKMPY's ROE is +0.16%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, HKMPY is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check ELTP's competition here
HKMPY vs PKBFF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, HKMPY is priced at $48.27, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas PKBFF's P/E ratio is N/A. In terms of profitability, HKMPY's ROE is +0.16%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HKMPY is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check PKBFF's competition here
HKMPY vs GLASF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, GLASF has a market cap of 533M. Regarding current trading prices, HKMPY is priced at $48.27, while GLASF trades at $7.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas GLASF's P/E ratio is -83.89. In terms of profitability, HKMPY's ROE is +0.16%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, HKMPY is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check GLASF's competition here
HKMPY vs CCHWF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, HKMPY is priced at $48.27, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HKMPY's ROE is +0.16%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, HKMPY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CCHWF's competition here
HKMPY vs KHTRF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, KHTRF has a market cap of 464.4M. Regarding current trading prices, HKMPY is priced at $48.27, while KHTRF trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas KHTRF's P/E ratio is 66.57. In terms of profitability, HKMPY's ROE is +0.16%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, HKMPY is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check KHTRF's competition here
HKMPY vs PEXXF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, HKMPY is priced at $48.27, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HKMPY's ROE is +0.16%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HKMPY is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check PEXXF's competition here
HKMPY vs BOIRF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, BOIRF has a market cap of 421.9M. Regarding current trading prices, HKMPY is priced at $48.27, while BOIRF trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas BOIRF's P/E ratio is 31.97. In terms of profitability, HKMPY's ROE is +0.16%, compared to BOIRF's ROE of +0.03%. Regarding short-term risk, HKMPY is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check BOIRF's competition here
HKMPY vs AGYTF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, HKMPY is priced at $48.27, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, HKMPY's ROE is +0.16%, compared to AGYTF's ROE of -13.93%. Regarding short-term risk, HKMPY is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check AGYTF's competition here
HKMPY vs HUMDF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HUMDF has a market cap of 404.2M. Regarding current trading prices, HKMPY is priced at $48.27, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, HKMPY's ROE is +0.16%, compared to HUMDF's ROE of +2.11%. Regarding short-term risk, HKMPY is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check HUMDF's competition here
HKMPY vs CRLBF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CRLBF has a market cap of 374.3M. Regarding current trading prices, HKMPY is priced at $48.27, while CRLBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CRLBF's P/E ratio is -7.91. In terms of profitability, HKMPY's ROE is +0.16%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, HKMPY is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CRLBF's competition here
HKMPY vs NIKA Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, NIKA has a market cap of 360.3M. Regarding current trading prices, HKMPY is priced at $48.27, while NIKA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas NIKA's P/E ratio is N/A. In terms of profitability, HKMPY's ROE is +0.16%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, HKMPY is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check NIKA's competition here
HKMPY vs CPHRF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CPHRF has a market cap of 266.7M. Regarding current trading prices, HKMPY is priced at $48.27, while CPHRF trades at $10.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CPHRF's P/E ratio is 22.63. In terms of profitability, HKMPY's ROE is +0.16%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, HKMPY is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CPHRF's competition here
HKMPY vs BHCCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, HKMPY is priced at $48.27, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HKMPY's ROE is +0.16%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, HKMPY is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check BHCCF's competition here
HKMPY vs BIOIF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, BIOIF has a market cap of 204.2M. Regarding current trading prices, HKMPY is priced at $48.27, while BIOIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas BIOIF's P/E ratio is -0.02. In terms of profitability, HKMPY's ROE is +0.16%, compared to BIOIF's ROE of -10.85%. Regarding short-term risk, HKMPY is more volatile compared to BIOIF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check BIOIF's competition here
HKMPY vs PLNHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, HKMPY is priced at $48.27, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HKMPY's ROE is +0.16%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, HKMPY is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check PLNHF's competition here
HKMPY vs RDDTF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, RDDTF has a market cap of 195.3M. Regarding current trading prices, HKMPY is priced at $48.27, while RDDTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas RDDTF's P/E ratio is -0.01. In terms of profitability, HKMPY's ROE is +0.16%, compared to RDDTF's ROE of +0.00%. Regarding short-term risk, HKMPY is more volatile compared to RDDTF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check RDDTF's competition here
HKMPY vs CBWTF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CBWTF has a market cap of 164M. Regarding current trading prices, HKMPY is priced at $48.27, while CBWTF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CBWTF's P/E ratio is 6.10. In terms of profitability, HKMPY's ROE is +0.16%, compared to CBWTF's ROE of +0.20%. Regarding short-term risk, HKMPY is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check CBWTF's competition here
HKMPY vs PHCUF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, PHCUF has a market cap of 156.6M. Regarding current trading prices, HKMPY is priced at $48.27, while PHCUF trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas PHCUF's P/E ratio is -293.74. In terms of profitability, HKMPY's ROE is +0.16%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, HKMPY is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check PHCUF's competition here
HKMPY vs JUSHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, JUSHF has a market cap of 132.9M. Regarding current trading prices, HKMPY is priced at $48.27, while JUSHF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas JUSHF's P/E ratio is -2.25. In terms of profitability, HKMPY's ROE is +0.16%, compared to JUSHF's ROE of +1.20%. Regarding short-term risk, HKMPY is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check JUSHF's competition here
HKMPY vs COPHF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, HKMPY is priced at $48.27, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HKMPY's ROE is +0.16%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HKMPY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check COPHF's competition here
HKMPY vs AAWH Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, AAWH has a market cap of 129.9M. Regarding current trading prices, HKMPY is priced at $48.27, while AAWH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas AAWH's P/E ratio is -1.52. In terms of profitability, HKMPY's ROE is +0.16%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, HKMPY is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check AAWH's competition here
HKMPY vs STMH Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, STMH has a market cap of 125.6M. Regarding current trading prices, HKMPY is priced at $48.27, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas STMH's P/E ratio is N/A. In terms of profitability, HKMPY's ROE is +0.16%, compared to STMH's ROE of -2.75%. Regarding short-term risk, HKMPY is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check STMH's competition here
HKMPY vs LOVFF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LOVFF has a market cap of 125.3M. Regarding current trading prices, HKMPY is priced at $48.27, while LOVFF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LOVFF's P/E ratio is 11.42. In terms of profitability, HKMPY's ROE is +0.16%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, HKMPY is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check LOVFF's competition here
HKMPY vs NWPN Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, HKMPY is priced at $48.27, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas NWPN's P/E ratio is -0.04. In terms of profitability, HKMPY's ROE is +0.16%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, HKMPY is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check NWPN's competition here
HKMPY vs HLTRF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, HLTRF has a market cap of 117.4M. Regarding current trading prices, HKMPY is priced at $48.27, while HLTRF trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas HLTRF's P/E ratio is -6.56. In terms of profitability, HKMPY's ROE is +0.16%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, HKMPY is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check HLTRF's competition here
HKMPY vs GRUSF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, GRUSF has a market cap of 111.5M. Regarding current trading prices, HKMPY is priced at $48.27, while GRUSF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas GRUSF's P/E ratio is 22.50. In terms of profitability, HKMPY's ROE is +0.16%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, HKMPY is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check GRUSF's competition here
HKMPY vs LPCUF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, HKMPY is priced at $48.27, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, HKMPY's ROE is +0.16%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, HKMPY is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check LPCUF's competition here
HKMPY vs CNVCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, HKMPY is priced at $48.27, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HKMPY's ROE is +0.16%, compared to CNVCF's ROE of -3.90%. Regarding short-term risk, HKMPY is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check CNVCF's competition here
HKMPY vs PLNH Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, PLNH has a market cap of 94.7M. Regarding current trading prices, HKMPY is priced at $48.27, while PLNH trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas PLNH's P/E ratio is -2.08. In terms of profitability, HKMPY's ROE is +0.16%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, HKMPY is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check PLNH's competition here
HKMPY vs BIOYF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, BIOYF has a market cap of 94.1M. Regarding current trading prices, HKMPY is priced at $48.27, while BIOYF trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas BIOYF's P/E ratio is 16.73. In terms of profitability, HKMPY's ROE is +0.16%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, HKMPY is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for HKMPY.Check BIOYF's competition here
HKMPY vs LRDSF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, LRDSF has a market cap of 83.9M. Regarding current trading prices, HKMPY is priced at $48.27, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, HKMPY's ROE is +0.16%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, HKMPY is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check LRDSF's competition here
HKMPY vs ABSCF Comparison August 2025
HKMPY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HKMPY stands at 5.3B. In comparison, ABSCF has a market cap of 80.3M. Regarding current trading prices, HKMPY is priced at $48.27, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HKMPY currently has a P/E ratio of 14.45, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, HKMPY's ROE is +0.16%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, HKMPY is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for HKMPY.Check ABSCF's competition here